Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis

BACKGROUND: In the last years, levothyroxine (LT4) has been commercialized also in liquid formulation, which is less sensitive to the factors known to reduce the absorption of tablet LT4. To date, there is no robust information that liquid LT4 can improve pharmacologic thyroid homeostasis of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Virili, Camilla, Giovanella, Luca, Fallahi, Poupak, Antonelli, Alessandro, Santaguida, Maria Giulia, Centanni, Marco, Trimboli, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790785/
https://www.ncbi.nlm.nih.gov/pubmed/29434573
http://dx.doi.org/10.3389/fendo.2018.00010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790785/
https://www.ncbi.nlm.nih.gov/pubmed/29434573
http://dx.doi.org/10.3389/fendo.2018.00010

Ejemplares similares